Struthers Richard Scott sold CRNX
September 26, 2025 · Form 4 insider transaction
Struthers Richard Scott sold 4,000 shares of Crinetics Pharmaceuticals Inc at $45.00 per share, a transaction worth $180.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Disposed (sell-side)
Shares
4,000
Price
$45.00
Total value
$180.0K
InsiderStruthers Richard Scott
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateSeptember 26, 2025
Filing dateSeptember 30, 2025
Shares owned after106,000
OwnershipIndirect
10b5-1 planYes
AmendedNo
Footnotes
The sale reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 30, 2024.; The common stock was sold by the Reporting Person in open market transactions on the transaction date, with a sale price of $45.00 per share.